Puma Biotechnology Inc (PBYI) Financials
PBYI Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 230.5 million | 177.1 million |
2023-09-30 | 203.6 million | 164.9 million |
2023-06-30 | 200.5 million | 170.1 million |
2023-03-31 | 196.3 million | 170.4 million |
PBYI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 10.4 million | 2.4 million |
2023-09-30 | 10.6 million | 2.5 million |
2023-06-30 | 3.2 million | 2.4 million |
2023-03-31 | -9.9 million | 2.8 million |
PBYI Net Income
No data available :(
PBYI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 95.9 million | - | 11.8 million |
2023-09-30 | 85.0 million | - | 12.9 million |
2023-06-30 | 74.4 million | - | 14.0 million |
2023-03-31 | 71.2 million | - | 15.0 million |
PBYI Shares Outstanding
PBYI Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 45000 | 12.9 million | 19.8 million | 367000 |
2023-09-30 | 27000 | 11.4 million | 22.2 million | - |
2023-06-30 | 68000 | 13.4 million | 24.5 million | - |
2023-03-31 | 12.5 million | 12.7 million | 22.5 million | - |
PBYI Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 72.2 million | 24.3 million |
2023-09-30 | 56.1 million | 13.3 million |
2023-06-30 | 54.6 million | 11.9 million |
2023-03-31 | 52.8 million | 13.2 million |
PBYI
Price: $4.95
52 week price:
Earnings Per Share: 0.45 USD
P/E Ratio: 72
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 234700
Ebitda: -76.5 millionMarket Capitalization: 272.9 million